Citi-coline for babies who had low oxygen at birth
Part of Genetic & congenital clinical trials.
This trial studies whether a medicine called citicoline can protect the brain in newborns who had low oxygen (hypoxia). It may help reduce brain injury in babies, but it does not include babies with a specific severe brain condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a newborn baby who experienced low oxygen (hypoxia) around birth
- Do not have hypoxic ischemic encephalopathy (a specific severe brain injury from low oxygen)
- Be eligible for study screening based on the medical cause of the low-oxygen event
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study tests whether citicoline can act as a protective treatment for the brain in babies born early and needing breathing support. It may help reduce risks tied to prematurity and breathing complications by supporting the brain’s health.
This study tests a medicine called citicoline to see if it can help babies who had a lack of oxygen around birth (which can lead to brain injury). The goal is to reduce brain damage and improve recovery.
This trial tests if giving caffeine to newborns who had low oxygen at birth can help protect their brains. It compares caffeine plus standard care to placebo plus standard care for moderate to severe hypoxic ischemic encephalopathy (HIE).
This trial studies outcomes in newborns who had breathing problems from low oxygen before or during birth and were treated with a cooling therapy (therapeutic hypothermia). It may help doctors understand which babies benefit most and what recovery looks like over time.
This study tests whether adding a medication called sildenafil (commonly used for blood pressure) to standard cooling treatment can improve brain recovery in newborn babies with brain injury from lack of oxygen. It aims to see if the combination is safe and effective in helping these babies develop better.
This early-phase study tests whether using a baby’s own cord blood stem cells is safe and feasible for newborns with brain injury from lack of oxygen around birth. It may help researchers find new ways to treat hypoxic-ischemic encephalopathy (brain injury due to oxygen deprivation) in addition to standard care like cooling.
Hear when a new Neonatal Hypoxia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.